New product: Lovima and Hana (desogestrel) 75 microgram film-coated tablets

This oral contraception, indicated for women of childbearing age including adolescents, is now available as a Pharmacy (P) medicine.

SPS commentary:

The MHRA public assessment reports contain further information on how the reclassification proposals were assessed, including potential risks and drug interactions, and details of risk management plans and pharmacy support materials.

Source:

electronic Medicines compendium

Resource links:

Hana public assessment report

Lovima public assessment report